View of In Silico Identification of Promising PDE5 Inhibitors Against Hepatocellular Carcinoma among recently FDA approved drug: A Docking and ADMET Study

Return to Article Details In Silico Identification of Promising PDE5 Inhibitors Against Hepatocellular Carcinoma among recently FDA approved drug: A Docking and ADMET Study Download Download PDF